Business profile not generated.
Run python -m application.cli.business_profile run --market US --one PTPI, then regenerate the site.
Issue 000 | U.S. Pilot | US
PTPI
Petros Pharmaceuticals, Inc.
Passing
Verified
10-Q | 2026-05-13
Filing currency: USD
Margin of Safety
88.0%
GNNI internal calculation. Market context inputs are retained internally and are not displayed.
- Current Assets
- 4,394,450USD
- Total Liabilities
- 2,623,135USD
- NCAV
- 1,771,315USD
- Cash
- 4,352,450USD
- NCAV per share
- 0.04USD/share
- Evidence
- 6 annual | 20 quarterly
Business Profile
Checklist-driven facts extracted from filing text. Missing fields stay visible.
Known Unknowns
Medium | Share Count
Issue 000 does not yet evaluate share count trend or post-filing dilution beyond Mary's screening flags.
Low | Classification
U.S. Pilot rows are surfaced for source inspection and may still need manual business classification review.
Annual Financials
Latest annual periods, newest first. Missing cells render as n/a.
| Metric |
2025-12-31
10-K
USD
|
2024-12-31
10-K
USD
|
2023-12-31
10-K
USD
|
2022-12-31
10-K
USD
|
2021-12-31
10-K
USD
|
2020-12-31
10-K
USD
|
|---|---|---|---|---|---|---|
| Revenue | n/a | 5,112,043 | 5,822,388 | 5,992,054 | 7,811,264 | 9,559,469 |
| Operating Income | -4,641,350 | -17,679,650 | -13,617,364 | -19,915,749 | -18,048,016 | -17,282,039 |
| Net Income | 1,913,595 | -14,318,790 | -8,163,188 | -20,037,573 | -8,986,676 | -20,585,925 |
| Cash From Operations | -6,734,707 | -2,603,051 | -7,626,529 | -12,797,325 | -11,862,031 | -15,305,325 |
| Capex | n/a | -24,587 | n/a | n/a | n/a | -4,633 |
| Free Cash Flow | n/a | -2,627,638 | n/a | n/a | n/a | -15,309,958 |
| Cash And Equivalents | 5,136,722 | 3,709,971 | 13,300,000 | 9,426,264 | 23,847,572 | 17,139,694 |
| Accounts Receivable | n/a | 416,076 | 2,226,151 | 2,110,246 | 2,455,386 | 5,152,969 |
| Inventory | n/a | 1,349,802 | 1,610,391 | 1,815,113 | 519,649 | 760,530 |
| Total Current Assets | 5,163,598 | 7,294,278 | 20,390,396 | 14,667,905 | 30,542,695 | 25,905,053 |
| Total Assets | 5,163,598 | 10,635,310 | 33,795,795 | 32,421,214 | 67,390,058 | 69,854,014 |
| Total Current Liabilities | 2,292,744 | 18,027,665 | 10,770,751 | 7,067,976 | 30,980,076 | 41,894,042 |
| Total Liabilities | 2,292,744 | 18,102,888 | 21,315,772 | 15,718,747 | 31,845,094 | 52,384,962 |
| Shareholders Equity | 2,870,854 | -7,467,578 | 12,071,041 | 16,702,467 | 35,544,964 | 17,469,052 |
| Shares Outstanding | 42,284,502 | 10,528,103 | 2,991,377 | 2,079,387 | 20,684,723 | 9,707,655 |
| Shares Outstanding Diluted | n/a | n/a | n/a | n/a | n/a | n/a |
| Weighted Avg Shares Diluted | 28,065,362 | 8,026,038 | 2,176,017 | 2,070,210 | 10,889,766 | 5,340,682 |
| Weighted Avg Shares Basic | 28,065,362 | 8,026,038 | 2,176,017 | 2,070,210 | 10,889,766 | 5,340,682 |
Quarterly Financials
Latest quarterly periods, newest first. Periods are shown only when Data Vault has them.
| Metric |
2026-03-31
10-Q
USD
|
2025-12-31
10-K
USD
|
2025-09-30
10-Q
USD
|
2025-06-30
10-Q
USD
|
2025-03-31
10-Q
USD
|
2024-12-31
10-K
USD
|
2024-09-30
10-Q
USD
|
2024-06-30
10-Q
USD
|
2024-03-31
10-Q
USD
|
2023-12-31
10-K
USD
|
2023-09-30
10-Q
USD
|
2023-06-30
10-Q
USD
|
2023-03-31
10-Q
USD
|
2022-12-31
10-K
USD
|
2022-09-30
10-Q
USD
|
2022-06-30
10-Q
USD
|
2022-03-31
10-Q
USD
|
2021-12-31
10-K
USD
|
2021-09-30
10-Q
USD
|
2021-06-30
10-Q
USD
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | n/a | n/a | n/a | n/a | n/a | 725,403 | 1,576,364 | 1,421,470 | 1,388,806 | -364,250 | 1,674,655 | 1,994,011 | 2,517,972 | 798,101 | -1,457,732 | 4,186,516 | 2,465,169 | -867,160 | 2,145,169 | 2,457,649 |
| Operating Income | -1,027,179 | -391,486 | -990,737 | -1,800,778 | -1,458,349 | -9,130,722 | -2,339,750 | -2,280,905 | -3,928,273 | -5,038,618 | -4,806,641 | -2,462,808 | -1,309,297 | -4,101,112 | -13,672,019 | -1,661,420 | -481,198 | -7,973,200 | -3,596,617 | -4,280,692 |
| Net Income | -987,036 | -5,769,352 | 4,510,123 | 5,432,846 | -2,260,022 | -9,273,440 | -2,220,661 | -662,026 | -2,162,663 | 318,150 | -4,549,508 | -2,546,683 | -1,385,147 | -4,221,360 | -13,830,197 | -1,811,792 | -174,224 | -8,185,942 | -1,696,898 | -2,112,917 |
| Cash From Operations | -784,272 | -933,544 | -1,133,924 | -3,007,151 | -1,660,088 | 965,405 | -771,246 | -1,662,362 | -1,134,848 | -2,259,894 | -4,046,202 | -572,070 | -748,363 | -1,570,340 | -1,751,476 | -4,199,808 | -5,275,701 | -8,304,299 | -1,211,366 | -1,899,785 |
| Capex | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Free Cash Flow | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Cash And Equivalents | 4,352,450 | 5,136,722 | 6,070,266 | 7,321,501 | 8,931,054 | 3,709,971 | 3,900,000 | 7,500,000 | 11,100,000 | 13,300,000 | 18,000,000 | 7,400,000 | 8,300,000 | 9,426,264 | 11,200,000 | 13,295,089 | 17,671,871 | 23,847,572 | 8,135,184 | 11,031,177 |
| Total Current Assets | 4,394,450 | 5,163,598 | 6,133,468 | 7,396,843 | 14,465,646 | 7,294,278 | 10,724,480 | 13,979,045 | 17,902,455 | 20,390,396 | 24,433,180 | 13,150,892 | 13,903,466 | 14,667,905 | 18,771,620 | 22,853,237 | 26,838,105 | 30,542,695 | 13,354,324 | 16,234,052 |
| Total Liabilities | 2,623,135 | 2,292,744 | 2,765,381 | 2,949,960 | 27,189,574 | 18,102,888 | 17,576,521 | 15,983,229 | 19,618,777 | 21,315,772 | 31,857,093 | 15,782,819 | 15,122,772 | 15,718,747 | 17,001,461 | 16,832,900 | 20,137,579 | 31,845,094 | 34,188,332 | 37,179,517 |
| Shares Outstanding | 42,372,502 | 42,284,502 | 42,284,502 | 42,284,502 | 2,052,762 | 10,528,103 | 10,014,872 | 9,297,538 | 6,881,864 | 2,991,377 | 2,119,620 | 2,119,620 | 2,088,698 | 2,079,387 | 20,708,024 | 20,684,723 | 20,684,723 | 20,684,723 | 9,826,599 | 9,826,599 |
| Shares Outstanding Diluted | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Weighted Avg Shares Diluted | 46,222,502 | 28,065,362 | 42,284,502 | 25,922,503 | 1,161,791 | 8,026,038 | 9,829,793 | 7,388,107 | 4,756,952 | 2,176,017 | 2,119,620 | 2,117,581 | 2,088,698 | 2,070,210 | 20,692,321 | 20,684,723 | 20,684,723 | 10,889,766 | 9,826,599 | 9,802,309 |
| Weighted Avg Shares Basic | 46,222,502 | 28,065,362 | 42,284,502 | 25,922,503 | 1,161,791 | 8,026,038 | 9,829,793 | 7,388,107 | 4,756,952 | 2,176,017 | 2,119,620 | 2,117,581 | 2,088,698 | 2,070,210 | 20,692,321 | 20,684,723 | 20,684,723 | 10,889,766 | 9,826,599 | 9,802,309 |
Audit Trail
NCAV Audit
Official-source inputs remain linked to filing provenance. Derived values are labeled as such.
| Input | Value | Source concept | Filing period | Confidence | Provenance |
|---|---|---|---|---|---|
| Current Assets | 4,394,450USD | us-gaap:AssetsCurrent | 2026-03-31 | 1.00 |
sec/companyfacts/cik=0001815903/companyfacts.json D:\Projects\The Data Vault\objects\sec\companyfacts\cik=0001815903\companyfacts.json |
| Total Liabilities | 2,623,135USD | us-gaap:Liabilities | 2026-03-31 | 1.00 |
sec/companyfacts/cik=0001815903/companyfacts.json D:\Projects\The Data Vault\objects\sec\companyfacts\cik=0001815903\companyfacts.json |
| Cash | 4,352,450USD | us-gaap:CashAndCashEquivalentsAtCarryingValue | 2026-03-31 | 1.00 |
sec/companyfacts/cik=0001815903/companyfacts.json D:\Projects\The Data Vault\objects\sec\companyfacts\cik=0001815903\companyfacts.json |
| Shares Outstanding | 42,372,502 | us-gaap:CommonStockSharesOutstanding | 2026-03-31 | 1.00 |
sec/companyfacts/cik=0001815903/companyfacts.json D:\Projects\The Data Vault\objects\sec\companyfacts\cik=0001815903\companyfacts.json |
| NCAV | 1,771,315USD | derived | 2026-03-31 | n/a | company-evidence-v1 | total_current_assets - total_liabilities |
| NCAV per share | 0.04USD | derived | 2026-03-31 | n/a | company-evidence-v1 | NCAV / shares_outstanding |
| Margin of Safety | 88.0% | derived | 2026-03-31 | n/a | gnni_publication_pack | internal_discount |
NCAV = total_current_assets - total_liabilities | NCAV per share = NCAV / shares_outstanding
Source Provenance
- Data Source
- Data Vault
- Data Vault Root
- D:\Projects\The Data Vault
- CIK
- 0001815903
- Company ID
- n/a
- Selected Annual Source
- D:\Projects\The Data Vault\objects\sec\companyfacts\cik=0001815903\companyfacts.json
- Selected Quarterly Source
- D:\Projects\The Data Vault\objects\sec\companyfacts\cik=0001815903\companyfacts.json
- Statement Extractor
- companyfacts-screener-v1
- View Extractor
- companyfacts-screener-v1
- Source Accession Count
- 20
- Imported At
- 2026-07-04T23:04:36+00:00
- Rendered At
- 2026-07-05T09:06:29+00:00
Run Audit
- Mary Run
- 1ec055d81d1a42a39490a83bb9e1f22f
- Mary As Of
- 2026-07-03
- Accession
- 0001104659-26-060359
- CIK
- 0001815903
- Mary Filing Date
- 2026-05-13
- Filing Currency
- USD
- Internal Discount
- 88.0%
- Source State
- Verified
- Market Context
- Not Displayed
- Market Policy
- internal_only_not_redistributed
- Share Trend
- Not Evaluated
- Dilution
- Needs Review
mary_run=1ec055d81d1a42a39490a83bb9e1f22f; mary_as_of=2026-07-03; mary_filing_date=2026-05-13; mary_accession=0001104659-26-060359; mary_cik=0001815903; gnni_supporting_filing_date=2026-05-13; internal_discount=0.880393; mary_reason=Mary's deterministic net-net screen flagged this candidate. The internal discount is shown; raw market-data fields are not published in this pilot.